부산대학교 도서관

Hughes R; Brailsford W; Ferreira J; Chalmers JD; Belvisi MG; Kocks JWH; Masters P; Thomson P; Łyżwa D; Rosengren S; Cooper JD; Russell REK; Saralaya D

International Journal of COPD, Vol 20, Iss Issue 1, Pp 3305-3315 (2025)

Nilsson M; Rhedin M; Hendrickx R; Berglund S; Piras A; Blomgran P; Cavallin A; Collins M; Dahl G; Dekkak B; Ericsson T; Hagberg N; Holmberg AA; Leffler A; Lundqvist AJ; Markou T; Pinkerton J; Rönnblom L; Siu S; Taylor V; Wennberg T; Zervas D; Laurence ADJ; Mitra S; Belvisi MG; Birrell M; Borde A

Drug Design, Development and Therapy, Vol 16, Pp 2901-2917 (2022)

Welham B; Southampton NIHR Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK.; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Bennett M; Southampton NIHR Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK.; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Ostridge K; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology R&D BioPharmaceuticals, Astrazeneca, Gothenburg, Sweden.; Guy M; Nuclear Medicine, Nuclear Medicine Physics and Radiopharmacy, University Hospital Southampton, Southampton, UK.; Zvavamwe C; Radiopharmacy Department, Nuclear Medicine Physics and Radiopharmacy, University Hospital Southampton, Southampton, UK.; Chilcott A; Nuclear Medicine, Nuclear Medicine Physics and Radiopharmacy, University Hospital Southampton, Southampton, UK.; Johns S; Nuclear Medicine, Nuclear Medicine Physics and Radiopharmacy, University Hospital Southampton, Southampton, UK.; Sundram F; Nuclear Medicine, Nuclear Medicine Physics and Radiopharmacy, University Hospital Southampton, Southampton, UK.; Spalluto CM; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Shaw E; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Harden S; Southampton NIHR Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK.; Department of Radiology, University Hospital Southampton, Southampton, UK.; Alzetani A; Southampton NIHR Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK.; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Lee P; Southampton NIHR Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK.; Lawson M; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Lackie P; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Michopoulou S; Nuclear Medicine, Nuclear Medicine Physics and Radiopharmacy, University Hospital Southampton, Southampton, UK.; Henley D; Radiopharmacy Department, Nuclear Medicine Physics and Radiopharmacy, University Hospital Southampton, Southampton, UK.; Kong A; Southampton NIHR Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK.; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Fazleen A; Southampton NIHR Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK.; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Cellura D; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; McCrae C; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, USA.; Platt A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Belvisi MG; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; National Heart and Lung Institute, Imperial College, London, UK.; Staples KJ; Southampton NIHR Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK.; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.; Wilkinson T; Southampton NIHR Respiratory Biomedical Research Centre, University Hospital Southampton, Southampton, UK.; Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK.

Publisher: European Respiratory Society Country of Publication: England NLM ID: 101671641 Publication Model: eCollection Cited Medium: Print ISSN: 2312-0541 (Print) Linking ISSN: 23120541 NLM ISO Abbreviation: ERJ Open Res Subsets: PubMed not MEDLINE

Patrick T; UCL Respiratory, University College London, London, UK.; Naidu SB; UCL Respiratory, University College London, London, UK.; Bhamani A; UCL Respiratory, University College London, London, UK.; Aboelhassan A; Royal Free London NHS Foundation Trust, London, UK.; Assiut University Faculty of Medicine, Chest Department, Asyut, Egypt.; Caño S; Clinical Development, Early Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Barcelona, Spain.; Belvisi MG; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Doffman SR; Clinical Development, Early Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Janes SM; Lungs for Living Research Centre, UCL Respiratory, University College London, London, UK.; Hurst JR; UCL Respiratory, University College London, London, UK.

Publisher: European Respiratory Society Country of Publication: England NLM ID: 101671641 Publication Model: eCollection Cited Medium: Print ISSN: 2312-0541 (Print) Linking ISSN: 23120541 NLM ISO Abbreviation: ERJ Open Res Subsets: PubMed not MEDLINE

Corren J; David Geffen School of Medicine at UCLA, Los Angeles, CA, USA.; Reid F; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Moate R; Biometrics and Statistical Innovation, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Jimenez E; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Barcelona, Spain.; Sadiq MW; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Williams A; Integrated Bioanalysis, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Cambridge, UK.; Rytelewski M; Translational Science and Experimental Medicine, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Cameron-Christie S; Centre for Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Muthas D; Translational Science and Experimental Medicine, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Georgi B; Translational Science and Experimental Medicine, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Brooks D; Patient Safety Pharmacovigilance, AstraZeneca, Gaithersburg, MD, USA.; Lindqvist E; Early Respiratory and Immunology Clinical Development, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Kell C; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Platt A; Translational Science and Experimental Medicine, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Belvisi MG; Research and Early Development, Respiratory and Immunology, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK.; Pandya H; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Publisher: European Respiratory Society Country of Publication: England NLM ID: 101671641 Publication Model: eCollection Cited Medium: Print ISSN: 2312-0541 (Print) Linking ISSN: 23120541 NLM ISO Abbreviation: ERJ Open Res Subsets: PubMed not MEDLINE

Jellesmark Jensen T; Clinical Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. Electronic address: tina.jellesmarkJensen@astrazeneca.com.; Riff C; Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Lund J; Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Jevnikar Z; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Belvisi MG; Respiratory Pharmacology, National Heart and Lung Institute, Imperial College London, London, United Kingdom; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Keen C; Clinical Development, Alexion, AstraZeneca Rare Disease, Barcelona, Spain.; Mäenpää J; Chief Medical Office, Research & Development, Patient Safety Biopharma, AstraZeneca, Gothenburg, Sweden.; Mo J; Chief Medical Office, Research & Development, Patient Safety Biopharma, AstraZeneca, Gothenburg, Sweden.; Nemes S; Early Biostats & Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Forte Soto P; Parexel Early Phase Clinical Unit, London, United Kingdom.; Platt A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Chetty R; Clinical Research, Celerion, Belfast, United Kingdom.; Singh D; Medicines Evaluation Unit, University of Manchester, Manchester University NHS Foundation Trust, Manchester, United Kingdom.; Dosanjh DPS; Clinical Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom; Birmingham Acute Care Research, Institute of Inflammation and Ageing, University of Birmingham, Birmingham, United Kingdom.; Zingmark P; Clinical Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Konstantinidis KV; Early Research & Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Hughes R; Clinical Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.

Publisher: Mosby Country of Publication: United States NLM ID: 1275002 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6825 (Electronic) Linking ISSN: 00916749 NLM ISO Abbreviation: J Allergy Clin Immunol Subsets: MEDLINE

Silverberg JI; The George Washington University School of Medicine and Health Sciences, Washington, DC, USA.; Mustapa MN; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Reid F; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Lei A; Patient Safety Biopharma, AstraZeneca, Barcelona, Spain.; Smith R; Respiratory & Immunology Biometrics and Statistical Innovation, Late Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Moate R; Respiratory & Immunology Biometrics and Statistical Innovation, Late Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Kelly A; Precision Medicine Discovery & Development, Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Chen R; Precision Medicine Discovery & Development, Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Gavala M; Precision Medicine Discovery & Development, Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.; Jimenez E; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Barcelona, Spain.; Belvisi MG; Research and Early Development, Respiratory and Immunology, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Sadiq MW; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Kell C; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Pandya HC; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9216037 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3083 (Electronic) Linking ISSN: 09269959 NLM ISO Abbreviation: J Eur Acad Dermatol Venereol Subsets: MEDLINE

Gopalakrishnan V; Bioinformatics, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Sparklin B; Bioinformatics, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Kim JH; Bacterial Vaccines, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Bouquet J; Bioinformatics, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Kehl M; Bacterial Vaccines, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Kenny T; Virology and Vaccine Discovery, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Morehouse C; Bioinformatics, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Caceres C; Translational Scientific Management, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Warrener P; Bacterial Vaccines, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Hristova VA; Dynamic Omics, Centre for Genomics Research (CGR), Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Wilson S; Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; Shandilya H; Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; Barnes A; Biologics Engineering, Oncology R&D, AstraZeneca, Gaithersburg, MD, USA.; Ruzin A; Translational Scientific Management, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Wang J; Quantitative Biology, Data Sciences and Quantitative Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Oberg L; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Angermann B; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; McCrae C; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Platt A; VP and Head of Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Muthas D; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Hess S; Dynamic Omics, Centre for Genomics Research (CGR), Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Tkaczyk C; Microbial Antibodies and Technologies, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Sellman BR; Bacterial Vaccines, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA.; Ostridge K; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK.; Belvisi MG; SVP and Head of Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Wilkinson TMA; Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK.; Staples KJ; Clinical & Experimental Sciences, University of Southampton Faculty of Medicine, Southampton, UK.; NIHR Southampton Biomedical Research Centre, University Hospital Southampton, Southampton, UK.; DiGiandomenico A; Microbial Antibodies and Technologies, Research and Early Development, Vaccines and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, USA. antonio.digiandomenico@astrazeneca.com.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE

Long MB; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.; Gilmour A; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.; Kehl M; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Tabor DE; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Keller AE; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Warrener P; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Gopalakrishnan V; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Rosengren S; Translational Science and Experimental Medicine, Respiratory & Immunology, Respiratory and Immunology, and.; Crichton ML; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.; McIntosh E; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.; Giam YH; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.; Keir HR; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.; Brailsford W; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and.; Hughes R; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom.; Belvisi MG; Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden; and.; Sellman BR; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; DiGiandomenico A; Vaccine and Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland.; Chalmers JD; Division of Molecular and Clinical Medicine, School of Medicine, University of Dundee, Dundee, United Kingdom.

Publisher: American Thoracic Society Country of Publication: United States NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE

Singh D; Medicines Evaluation Unit, Manchester University NHS Foundation Trust, University of Manchester, Manchester, UK.; Guller P; Clinical Development, Research and Early Development, Respiratory and Immunology, AstraZeneca, Gothenburg, Sweden.; Reid F; Clinical Development, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Doffman S; Clinical Development, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Seppälä U; Clinical Development, Research and Early Development, Respiratory and Immunology, AstraZeneca, Gothenburg, Sweden.; Psallidas I; Clinical Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Boston, MA, USA.; Moate R; Biometrics and Statistical Innovation, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Smith R; Biometrics and Statistical Innovation, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Kiraga J; Early Phase Clinical Operations, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Warsaw, Poland.; Jimenez E; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Barcelona, Spain.; Brooks D; Office of Chief Medical Officer, Patient Safety Pharmacovigilance, AstraZeneca, Gaithersburg, MD, USA.; Kelly A; Translational Science and Experimental Medicine, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Nordenmark LH; Late-stage Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Oslo, Norway.; Sadiq MW; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Caballero LM; Hospital de Mérida, Mérida, Spain.; Kell C; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Belvisi MG; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK.; Pandya H; Clinical Development, Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK hitesh.pandya@astrazeneca.com.

Publisher: European Respiratory Society Country of Publication: England NLM ID: 8803460 Publication Model: Electronic-Print Cited Medium: Internet ISSN: 1399-3003 (Electronic) Linking ISSN: 09031936 NLM ISO Abbreviation: Eur Respir J Subsets: MEDLINE

Pinkerton JW; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Preite S; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Piras A; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Zervas D; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Markou T; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Freeman MS; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Hofving T; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Ivarsson E; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Bonvini SJ; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Brailsford W; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Yrlid L; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Belvisi MG; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK.; Birrell MA; Early Respiratory & Immunology, Biopharmaceuticals R&D AstraZeneca, Gothenburg, Sweden. mark.birrell@astrazeneca.com.; Respiratory Pharmacology group, Airway Disease section, NHLI, Imperial College, London, UK. mark.birrell@astrazeneca.com.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE

Zhou XH; Patient Safety Biopharma, Chief Medical Office, Oncology R&D, AstraZeneca, Pepparedsleden 1, 431 51 Mölndal, Sweden.; Prothon S; Clinical Pharmacology & Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 431 51 Mölndal, Sweden.; L E; Early Clinical Development, Research and Early Development, Respiratory and Immunology (RI), BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 431 51 Mölndal, Sweden.; Ferrari N; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, UK.; Hezaveh K; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA.; Liu Z; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA.; Nemes S; BioPharma Early Biometrics and Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 431 51 Mölndal, Sweden.; Almquist J; Clinical Pharmacology & Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 431 51 Mölndal, Sweden.; Williams ML; Clinical Pharmacology & Quantitative Pharmacology, BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 431 51 Mölndal, Sweden.; Sobande O; Late-stage Development, Respiratory and Immunology (RI), Inhaled Clinical Development, Respiratory, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA.; Gottfridsson C; Cardiovascular Safety Centre of Excellence, Global Patient Safety, Chief Medical Office, Oncology R&D, AstraZeneca, Pepparedsleden 1, 431 51 Mölndal, Sweden.; Gochuico BR; Early Clinical Development, Research and Early Development, Respiratory and Immunology (RI), BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA.; Platt A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, UK.; Brohawn Z; Translational Science and Experimental Medicine, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA.; Belvisi MG; SVP and Head of Research and Early Development, Respiratory and Immunology (RI), BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 431 51 Mölndal, Sweden.; Respiratory Pharmacology, National heart and Lung Institute, Imperial College, London SW7 2AZ, UK.; Goldwater R; Parexel Early Phase Clinical Unit (Baltimore), Harbor Hospital, Baltimore, MD 21225, USA.; Hornberg E; Projects, Research and Early Development, Respiratory and Immunology (R&I), BioPharmaceuticals R&D, AstraZeneca, Pepparedsleden 1, 431 51 Mölndal, Sweden.; Owen CA; Early Clinical Development, Research and Early Development, Respiratory and Immunology (RI), BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD 20878, USA.

Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE

Haines J; Faculty of Biology, Medicine and Health, School of Biological Sciences, Division of Infection, Immunity & Respiratory Medicine, The University of Manchester, Manchester, UK.; NIHR-Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK.; Belvisi MG; Respiratory Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK.; Research and early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Dubuis EC; Respiratory Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK.; Dockry RJ; Faculty of Biology, Medicine and Health, School of Biological Sciences, Division of Infection, Immunity & Respiratory Medicine, The University of Manchester, Manchester, UK.; NIHR-Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK.; Holt KJ; Faculty of Biology, Medicine and Health, School of Biological Sciences, Division of Infection, Immunity & Respiratory Medicine, The University of Manchester, Manchester, UK.; NIHR-Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK.; Hull JH; Royal Brompton Hospital, London, UK.; Institute of Sport, Exercise and Health, Division of Surgery and Interventional Science, University College London, London, UK.; Yorke J; Faculty of Biology, Medicine and Health, School of Biological Sciences, Division of Infection, Immunity & Respiratory Medicine, The University of Manchester, Manchester, UK.; Faculty of Health and Social Sciences, School of Nursing, The Hong Kong Polytechnic University, Hong Kong.; Fowler SJ; Faculty of Biology, Medicine and Health, School of Biological Sciences, Division of Infection, Immunity & Respiratory Medicine, The University of Manchester, Manchester, UK.; NIHR-Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK.; Smith JA; Faculty of Biology, Medicine and Health, School of Biological Sciences, Division of Infection, Immunity & Respiratory Medicine, The University of Manchester, Manchester, UK.; NIHR-Manchester Biomedical Research Centre, Manchester University NHS Foundation Trust, Manchester, UK.

Publisher: European Respiratory Society Country of Publication: England NLM ID: 101671641 Publication Model: eCollection Cited Medium: Print ISSN: 2312-0541 (Print) Linking ISSN: 23120541 NLM ISO Abbreviation: ERJ Open Res Subsets: PubMed not MEDLINE

van Laar JM; Division of Internal Medicine and Dermatology, Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.; Lei A; Patient Safety BioPharmaceuticals, Chief Medical Office, R&D, AstraZeneca, Barcelona, Spain.; Safy-Khan M; Division of Internal Medicine and Dermatology, Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, The Netherlands.; Almquist J; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Belfield G; Translational Genomics, Discovery Biology SE, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Edman K; Mechanistic and Structural Biology, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Öberg L; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Angermann BR; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Dillmann I; Translational Genomics, Discovery Biology SE, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Berntsson P; Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Etal D; Translational Genomics, Discovery Biology SE, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Dainty I; Bioscience COPD/IPF, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Astbury C; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Belvisi MG; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology, National Heart and Lung Institute, Imperial College London, London, UK.; Nemes S; Early Biometrics and Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Platt A; Translational Science and Experimental Medicine, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Cambridge, UK.; Prothon S; Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Samuelsson S; Clinical Development, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Svanberg P; Drug Metabolism and Pharmacokinetics, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Keen C; Clinical Development, Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Publisher: WileyBlackwell Pub Country of Publication: United States NLM ID: 101474067 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1752-8062 (Electronic) Linking ISSN: 17528054 NLM ISO Abbreviation: Clin Transl Sci Subsets: MEDLINE

Saunders P; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Oxford University Hospitals NHS Trust, Oxford, United Kingdom.; Wu Z; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Fahy WA; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Stewart ID; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Saini G; Centre for Respiratory Research, NIHR Biomedical Research Centre, Translational Medical Sciences, University of Nottingham, Nottingham, United Kingdom.; Smith DJF; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Braybrooke R; Centre for Respiratory Research, NIHR Biomedical Research Centre, Translational Medical Sciences, University of Nottingham, Nottingham, United Kingdom.; Stock C; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Renzoni EA; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Johnson SR; Centre for Respiratory Research, NIHR Biomedical Research Centre, Translational Medical Sciences, University of Nottingham, Nottingham, United Kingdom.; Jenkins RG; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.; Belvisi MG; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden.; Smith JA; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Division of Infection, Immunity and Respiratory Medicine, The University of Manchester, Manchester, United Kingdom.; Maher TM; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Hastings Centre for Pulmonary Research and Division of Pulmonary, Critical Care and Sleep Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California.; Molyneaux PL; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Royal Brompton and Harefield Hospitals, Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom.

Publisher: American Thoracic Society Country of Publication: United States NLM ID: 101600811 Publication Model: Print Cited Medium: Internet ISSN: 2325-6621 (Electronic) Linking ISSN: 23256621 NLM ISO Abbreviation: Ann Am Thorac Soc Subsets: MEDLINE

Yoon M; Air Pollution Exposure Laboratory, Division of Respiratory Medicine, Department Medicine, Vancouver Coastal Health Research Institute, The University of British Columbia, Vancouver, BC, Canada.; Ryu MH; Air Pollution Exposure Laboratory, Division of Respiratory Medicine, Department Medicine, Vancouver Coastal Health Research Institute, The University of British Columbia, Vancouver, BC, Canada.; Huff RD; Air Pollution Exposure Laboratory, Division of Respiratory Medicine, Department Medicine, Vancouver Coastal Health Research Institute, The University of British Columbia, Vancouver, BC, Canada.; Belvisi MG; Research and Early Development, Respiratory Pharmacology Group, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Airway Disease, National Heart and Lung Institute, Imperial College London, London, UK.; Smith J; Division of Infection, Immunity, and Respiratory Medicine, University of Manchester, 16 Manchester Academic Health Sciences Centre, and Manchester University NHS Foundation 17 Trust, Manchester, UK.; Carlsten C; Air Pollution Exposure Laboratory, Division of Respiratory Medicine, Department Medicine, Vancouver Coastal Health Research Institute, The University of British Columbia, Vancouver, BC, Canada. carlsten@mail.ubc.ca.; The Lung Center, Vancouver General Hospital-Gordon and Leslie Diamond Health Care Centre, 2775 Laurel St. 7th Floor, Vancouver, BC, V5Z 1M9, Canada. carlsten@mail.ubc.ca.

Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101090633 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-993X (Electronic) Linking ISSN: 14659921 NLM ISO Abbreviation: Respir Res Subsets: MEDLINE

Sadiq MW; Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Asimus S; Clinical Pharmacology & Quantitative Pharmacology, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, Gaithersburg, MD, Sweden.; Belvisi MG; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Respiratory Pharmacology Group, National Heart & Lung Institute, Imperial College London, London, UK.; Brailsford W; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Fransson R; Advanced Drug Delivery, Pharmaceutical Sciences, R&D, AstraZeneca, Gothenburg, Sweden.; Fuhr R; Parexel Early Phase Clinical Unit, Berlin, Germany.; Hagberg A; Patient Safety, Respiratory & Immunology, Chief Medical Office, R&D, AstraZeneca, Gothenburg, Sweden.; Hashemi M; Early Biostats & Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Jellesmark Jensen T; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Jonsson J; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Keen C; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Körnicke T; Parexel Early Phase Clinical Unit, Berlin, Germany.; Kristensson C; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Mäenpää J; Patient Safety, Respiratory & Immunology, Chief Medical Office, R&D, AstraZeneca, Gothenburg, Sweden.; Necander S; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Nemes S; Early Biostats & Statistical Innovation, Data Science & AI, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Betts J; Research and Early Development, Respiratory & Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 7503323 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2125 (Electronic) Linking ISSN: 03065251 NLM ISO Abbreviation: Br J Clin Pharmacol Subsets: MEDLINE

Ptasinski VA; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Department of Experimental Medical Sciences.; Wallenberg Centre for Molecular Medicine, and.; Lund Stem Cell Center, Lund University, Lund, Sweden; and.; Stegmayr J; Department of Experimental Medical Sciences.; Wallenberg Centre for Molecular Medicine, and.; Lund Stem Cell Center, Lund University, Lund, Sweden; and.; Belvisi MG; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; National Heart and Lung Institute, Imperial College London, London, United Kingdom.; Wagner DE; Department of Experimental Medical Sciences.; Wallenberg Centre for Molecular Medicine, and.; Lund Stem Cell Center, Lund University, Lund, Sweden; and.; Murray LA; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.

Publisher: American Thoracic Society Country of Publication: United States NLM ID: 8917225 Publication Model: Print Cited Medium: Internet ISSN: 1535-4989 (Electronic) Linking ISSN: 10441549 NLM ISO Abbreviation: Am J Respir Cell Mol Biol Subsets: MEDLINE

Parikh A; Scadding GK; Gray P; Belvisi MG; Mitchell JA

Acta Oto-Laryngologica (ACTA OTOLARYNGOL), Apr2002; 122(3): 302-305. (4p)

Smith JA; Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Sciences Centre.; Manchester University National Health Service Foundation Trust, Manchester, United Kingdom.; Harle A; Division of Molecular and Clinical Cancer Sciences, Manchester Academic Health Sciences Centre, and.; The Christie National Health Service Foundation Trust, Manchester, United Kingdom.; Dockry R; Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Sciences Centre.; Manchester University National Health Service Foundation Trust, Manchester, United Kingdom.; Holt K; Division of Infection, Immunity and Respiratory Medicine, Manchester Academic Health Sciences Centre.; Manchester University National Health Service Foundation Trust, Manchester, United Kingdom.; Russell P; The Christie National Health Service Foundation Trust, Manchester, United Kingdom.; Molassiotis A; School of Nursing, Hong Kong Polytechnic University, Hung Hom, Hong Kong.; Yorke J; Division of Nursing, Midwifery and Social Work, University of Manchester, Manchester, United Kingdom.; The Christie National Health Service Foundation Trust, Manchester, United Kingdom.; Robinson R; Division of Airway Disease, Respiratory Pharmacology Group, National Heart and Lung Institute, Imperial College London, London, United Kingdom; and.; Birrell MA; Division of Airway Disease, Respiratory Pharmacology Group, National Heart and Lung Institute, Imperial College London, London, United Kingdom; and.; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Belvisi MG; Division of Airway Disease, Respiratory Pharmacology Group, National Heart and Lung Institute, Imperial College London, London, United Kingdom; and.; Research and Early Development, Respiratory and Immunology, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.; Blackhall F; Division of Molecular and Clinical Cancer Sciences, Manchester Academic Health Sciences Centre, and.; The Christie National Health Service Foundation Trust, Manchester, United Kingdom.

Publisher: American Thoracic Society Country of Publication: United States NLM ID: 9421642 Publication Model: Print Cited Medium: Internet ISSN: 1535-4970 (Electronic) Linking ISSN: 1073449X NLM ISO Abbreviation: Am J Respir Crit Care Med Subsets: MEDLINE